Metraipolis › archive › dc_f2f63d786ce8

Take Five: harmonization in personalized cancer vaccines for cancer immunotherapy — Europe PMC PMID:42595869

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42595869
DOI
10.1038/s12276-[numero omesso]-y
License (as archived)
solo-consultazione
Archived
2026-10-16T16:34:34.792Z
SHA-256 of the archived text
a0234a56fc01d360f5da0f553d48e1b2636f9bededd6df89f2aa1f6b9c0610dd
Stable URL of this page
https://metraipolis.com/documento/dc_f2f63d786ce8

How to cite

Take Five: harmonization in personalized cancer vaccines for cancer immunotherapy — Europe PMC PMID:42595869 — Europe PMC (en), https://europepmc.org/article/MED/42595869 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_f2f63d786ce8 (Metraipolis archive dc_f2f63d786ce8, sha256 a0234a56fc01d360f5da0f553d48e1b2636f9bededd6df89f2aa1f6b9c0610dd)
BibTeX
@misc{dcf2f63d786ce8,
  title = {Take Five: harmonization in personalized cancer vaccines for cancer immunotherapy — Europe PMC PMID:42595869},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42595869},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_f2f63d786ce8; sha256 a0234a56fc01d360f5da0f553d48e1b2636f9bededd6df89f2aa1f6b9c0610dd},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42595869. Agents can read the archived copy with the MCP tool read_document.